KBC Group
INDV icon

KBC Group’s Indivior Pharmaceuticals INDV Stock Holding History

KBC Group’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.73M Buy
76,175
+344
+0.5% +$13K 0.01% 613
2026
Q2 		$3.11M Hold
75,831
– – 0.01% 591
2026
Q1 		$2.31M Buy
75,831
+72,523
+2,192% +$2.4M 0.01% 632
2025
Q4 		$119K Hold
3,308
– – ﹤0.01% 1177
2025
Q3 		$80K Buy
+3,308
New +$69.2K ﹤0.01% 1396

Other funds holding INDV

Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
BI Asset Management Fondsmaeglerselskab
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Exchange Traded Concepts
Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return
Virginia Retirement Systems
Virginia Retirement Systems Richmond, Virginia $16.3B AUM 35.33% 1-Year Est. Return

KBC Group's INDV Position: Q3 2026 in Review

KBC Group increased its Indivior Pharmaceuticals (INDV) stake by 0.45% in Q3 2026, buying an estimated $13K and bringing the position to 76,175 shares worth $2.73M. The position accounts for 0.01% of the portfolio, ranked #613.

KBC Group first reported a position in INDV in Q3 2025 and has held it in 5 quarters since. The position peaked at $3.11M in Q2 2026. 76 funds tracked by Wall St. Rank hold INDV as of Q3 2026.

  • KBC Group held 76,175 shares of Indivior Pharmaceuticals worth $2.73M as of Q3 2026.
  • KBC Group bought 344 Indivior Pharmaceuticals shares in Q3 2026, an estimated $13K.
  • Indivior Pharmaceuticals made up 0.01% of KBC Group's portfolio in Q3 2026, its #613 holding.
  • KBC Group first reported a position in Indivior Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
  • KBC Group's Indivior Pharmaceuticals position peaked at $3.11M in Q2 2026.
  • 76 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q3 2026.

Based on KBC Group's 13F filing for Q3 2026, filed 22 Oct 2026.